Skip to main content
. 2013 Jun 1;1(1):45–51. doi: 10.12945/j.aorta.2013.13.002

Table 3.

Comparison of the Effects of β-Blockers on Patients without Marfan Syndrome in Four Separate Clinical Trials

Control group
 Treatment group
Patients Growth Patients Growth
Propranolol Aneurysm Trial Investigators [18] 272 0.26 cm/y 276 0.22 cm/y
Wilmink et al. [19] 221 0.25 mm 256 0.24 mm
Leach et al. [20] 15 0.44 cm/y 12 0.17 cm/y
Gadowski et al. [21] 83 0.68 cm/y 38 0.36 cm/y